LV10190A - Panemiens alkoholisma arstesanai ar naimifinu - Google Patents

Panemiens alkoholisma arstesanai ar naimifinu

Info

Publication number
LV10190A
LV10190A LV931052A LV931052A LV10190A LV 10190 A LV10190 A LV 10190A LV 931052 A LV931052 A LV 931052A LV 931052 A LV931052 A LV 931052A LV 10190 A LV10190 A LV 10190A
Authority
LV
Latvia
Prior art keywords
naimifin
drop
alcoholism treatment
alcoholism
treatment
Prior art date
Application number
LV931052A
Other languages
English (en)
Other versions
LV10190B (en
Inventor
John D Sinclair
Harry Scheinin
Risto Lammintausta
Original Assignee
Alko Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alko Ltd filed Critical Alko Ltd
Publication of LV10190A publication Critical patent/LV10190A/lv
Publication of LV10190B publication Critical patent/LV10190B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-93-1052A 1990-06-04 1993-08-31 Method for treating alcoholism with nalmefene LV10190B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/532,424 US5086058A (en) 1990-06-04 1990-06-04 Method for treating alcoholism with nalmefene
PCT/US1991/003241 WO1991018605A1 (en) 1990-06-04 1991-05-10 Method for treating alcoholism with nalmefene

Publications (2)

Publication Number Publication Date
LV10190A true LV10190A (lv) 1994-10-20
LV10190B LV10190B (en) 1995-06-20

Family

ID=24121726

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1052A LV10190B (en) 1990-06-04 1993-08-31 Method for treating alcoholism with nalmefene

Country Status (19)

Country Link
US (1) US5086058A (lv)
EP (1) EP0531415B1 (lv)
JP (1) JP3059213B2 (lv)
AT (1) ATE145329T1 (lv)
AU (1) AU642748B2 (lv)
CA (1) CA2084519C (lv)
DE (1) DE69123247T2 (lv)
DK (1) DK0531415T3 (lv)
ES (1) ES2097209T3 (lv)
FI (1) FI925513A (lv)
GR (1) GR3022289T3 (lv)
HU (1) HU210637B (lv)
IE (1) IE77333B1 (lv)
LT (1) LT3893B (lv)
LV (1) LV10190B (lv)
NZ (1) NZ238391A (lv)
RU (1) RU2090190C1 (lv)
WO (1) WO1991018605A1 (lv)
ZA (1) ZA914185B (lv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
US6271239B1 (en) * 1992-04-13 2001-08-07 Regents Of The University Of Minnesota Delta opioid receptor-selective benzylidene-substituted morphinans
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
US5298622A (en) * 1993-05-12 1994-03-29 Regents Of The University Of Minnesota Spiroindane opiate analogs
US5457208A (en) 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
US5587381A (en) * 1995-03-27 1996-12-24 Sinclair; John D. Method for terminating methadone maintenance through extinction of the opiate-taking responses
WO1997018781A1 (en) * 1995-11-20 1997-05-29 University Of Miami Method of treating nicotine dependence
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US5780479A (en) * 1997-04-04 1998-07-14 Regents Of The University Of Minnesota Use of opioid antagonists to treat impulse-control disorders
JP2001526229A (ja) 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． オピオイド投薬剤形の乱用を防止する方法
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
HU1500214D0 (hu) 1997-12-22 2002-03-28 Euro Celtique Sa Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
EP1248800A2 (en) * 1999-11-30 2002-10-16 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
OA12215A (en) 2000-02-08 2006-05-09 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations.
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US20040024004A1 (en) * 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
US6528520B2 (en) * 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
US6262062B1 (en) * 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
ES2361148T3 (es) 2001-05-11 2011-06-14 Endo Pharmaceuticals Inc. Forma de dosificación de opioides de liberación controlada resistente al abuso.
ATE540613T1 (de) * 2001-07-13 2012-01-15 Arkray Inc Analysevorrichtung und durchstechelement- integrierte verbindung für eine konzentrationsanalysevorrichtung
DE60230632D1 (de) * 2001-07-18 2009-02-12 Euro Celtique Sa Pharmazeutische kombinationen von oxycodon und naloxon
IS7142A (is) 2001-08-06 2004-02-05 Euroceltique S.A. Lyfjasamsetningar, sem innihalda morfíngerandaefni, ásamt losanlegu en hömdu mótlyfi
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
AU2002324624A1 (en) * 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
JP2005508888A (ja) * 2001-08-14 2005-04-07 バイオティ セラピーズ コーポレイション アルコール依存症またはアルコール中毒を治療する方法
EP2425823A1 (en) 2002-04-05 2012-03-07 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
EP1551372B8 (en) * 2002-09-20 2018-08-01 Alpharma Pharmaceuticals LLC Sequestering subunit and related compositions and methods
EP1610791B1 (en) * 2003-03-31 2011-02-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
AU2004229551A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US20060009478A1 (en) * 2003-10-15 2006-01-12 Nadav Friedmann Methods for the treatment of back pain
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP2526932B1 (en) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Pharmaceutical composition
SI2724722T1 (sl) 2006-10-20 2017-07-31 Neurendo Pharma, Llc Postopek za obnovitev učinka inkretina
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
ATE523512T1 (de) * 2008-04-24 2011-09-15 Janssen Pharmaceutica Nv Nalmefen-prodrugs
KR101598138B1 (ko) * 2008-04-24 2016-02-29 얀센 파마슈티카 엔.브이. 날메펜 디에스테르 프로드럭
EP2317991B1 (en) * 2008-07-07 2017-05-03 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
US20140005217A1 (en) * 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
WO2014170353A1 (en) * 2013-04-17 2014-10-23 H. Lundbeck A/S Nalmefene for treatment of patients with sleep disorder
CN105517551A (zh) 2013-07-23 2016-04-20 欧洲凯尔特公司 用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合
US20170042887A1 (en) * 2014-04-22 2017-02-16 Otsuka Pharmaceutical. Co., Ltd. Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
EP3215154B1 (en) 2014-11-07 2020-01-29 Regents of the University of Minnesota Salts and compositions useful for treating disease
EP3445363A1 (en) * 2016-04-22 2019-02-27 Taiwanj Pharmaceuticals Co., Ltd. Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis or non-alcoholic fatty liver disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US5096715A (en) * 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist

Also Published As

Publication number Publication date
HU210637B (en) 1995-06-28
LV10190B (en) 1995-06-20
FI925513A0 (fi) 1992-12-04
JPH06506665A (ja) 1994-07-28
FI925513A (fi) 1992-12-04
GR3022289T3 (en) 1997-04-30
NZ238391A (en) 1997-06-24
HU9203835D0 (en) 1993-03-29
IE911888A1 (en) 1991-12-04
CA2084519C (en) 1999-02-09
EP0531415B1 (en) 1996-11-20
WO1991018605A1 (en) 1991-12-12
EP0531415A1 (en) 1993-03-17
LT3893B (en) 1996-04-25
LTIP1486A (en) 1995-09-25
AU642748B2 (en) 1993-10-28
JP3059213B2 (ja) 2000-07-04
ZA914185B (en) 1992-07-29
HUT65523A (en) 1994-06-28
AU7974091A (en) 1991-12-31
ES2097209T3 (es) 1997-04-01
IE77333B1 (en) 1997-12-03
RU2090190C1 (ru) 1997-09-20
CA2084519A1 (en) 1991-12-05
ATE145329T1 (de) 1996-12-15
DE69123247D1 (de) 1997-01-02
DE69123247T2 (de) 1998-01-15
US5086058A (en) 1992-02-04
DK0531415T3 (da) 1996-12-09

Similar Documents

Publication Publication Date Title
LV10190A (lv) Panemiens alkoholisma arstesanai ar naimifinu
RU92016403A (ru) Способ лечения алкоголизма налмефеном
MXPA99001239A (es) Proceso mejorado para la produccion de bebidas alcoholicas que utilizan semilla de malta.
EE9600187A (et) Filter jookide, peamiselt kohvi jaoks ja meetod selle tootmiseks
DE59308000D1 (de) Immunoassay zum nachweis von kollagen oder kollagenfragmenten
EP0668432A3 (en) Method for the treatment of oil field.
DE59004541D1 (de) Verfahren zum Vermindern des Alkoholgehaltes alkoholischer Getränke.
ZA957645B (en) A method for production of ethyl alcohol
DE3580611D1 (de) Verfahren zur herstellung alkoholischer getraenke.
DE68912312D1 (de) Vorrichtung zum schichtweisen herstellen von getränken.
EP0446817A3 (en) Method for reducing the search complexity in analysis-by-synthesis coding
ZA9472B (en) Process for producing low molecular-weight poly-1-olefins.
GR3015586T3 (en) Process for producing fuel oil and gas by cracking waste rubber.
MY119686A (en) Sequential distillation process for removing tetrahydroazepine from aminocapronitrile and/or hexamethylenediamine
ES2121554A1 (es) Procedimiento de obtencion de 14-hidroximorfinas mediante fotooxidacion de alcaloides morfinicos con sistema alcoxidienico en el anillo c.
AU5102490A (en) Process of treating alcoholic beverages by vapor-arbitrated pervaporisation
HUT60202A (en) Method for producing cork stopper
GR3024442T3 (en) Method to purify streptolysin o, intact streptolysin o obtainable by this method and its use
DE69417061T2 (de) Verfahren zur herstellung von 2-chlor-1, 3-butadien pfropfcopolymeren
ZA927725B (en) Process for producing chloroisocyanurates with hypochlorous acid.
NO950978D0 (no) Polyolefinbasert pigmentert blanding, samt fremgangsmåte for fremstilling av tilformede gjenstander med utgangspunkt i blandingen
HUT62119A (en) Cutting-clamping contact sleeve, as well as method for making said contact sleeve
KR900002724A (ko) 오징어를 이용한 술병의 제조방법
DE69029831D1 (de) Verfahren zur herstellung alkoholischer getränke
KR970008196U (ko) 인서트 사출방식에 의한 물안경